Literature DB >> 21743218

Poor prognostic factors of lupus nephritis.

Khawla Kammoun1, Faigal Jarraya, Lamia Bouhamed, Mahmoud Kharrat, Saloua Makni, Mohamed Ben Hmida, Hafedh Makni, Neila Kaddour, Tahia Boudawara, Zouhir Bahloul, Jamil Hachicha.   

Abstract

The occurrence of renal involvement during the clinical course of systemic lupus erythematous (SLE) is generally considered to be the most important factor influencing the prognosis in terms of morbidity and mortality. The factors influencing prognosis in lupus nephritis (LN) are variable in literature. Our aim was to determine predictive factors of poor prognosis in LN among our population. In this retrospective study, 82 cases of LN observed over 18 years were studied. There were 12 males and 70 females with a mean age of 26.9 ± 11 years. At presentation, the mean proteinuria was 3.9 ± 4 g/day; the nephrotic syndrome, hematuria, leukocyturia and renal failure were observed in 67.1%, 63.4%, 56.1% and 37.8% of cases, respectively. LN was of class I, II, III, IV and V in 4.9%, 13.4%, 23.2%, 50% and 8.5% of the cases, respectively. Fifteen patients developed end-stage renal failure and/or died. The presence of hypertension, renal failure, massive proteinuria and high activity index score of LN was associated with poor renal prognosis.

Entities:  

Mesh:

Year:  2011        PMID: 21743218

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  9 in total

1.  Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

Authors:  M Pejchinovski; J Siwy; W Mullen; H Mischak; M A Petri; L C Burkly; R Wei
Journal:  Lupus       Date:  2017-05-05       Impact factor: 2.911

2.  Persistent hypertension in lupus nephritis and the associated risk factors.

Authors:  Syahrul Syazliana Shaharir; Ruslinda Mustafar; Rozita Mohd; Mohd Shahrir Mohd Said; Halim A Gafor
Journal:  Clin Rheumatol       Date:  2014-11-06       Impact factor: 2.980

Review 3.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

Review 4.  Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female mice.

Authors:  David A Hart
Journal:  Biol Sex Differ       Date:  2016-06-27       Impact factor: 5.027

5.  Long-term Outcome of Lupus Nephritis: A Single Center Study.

Authors:  M Limesh; Prashanth G Kedlaya; S Renuka; N Vinod
Journal:  Indian J Nephrol       Date:  2021-06-19

6.  Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Authors:  Gebre-Mariam Tsegay Hailu; Shemsu Umer Hussen; Seifemichael Getachew; Alemseged Beyene Berha
Journal:  BMC Nephrol       Date:  2022-06-17       Impact factor: 2.585

7.  Prognostic significance of hypertension at the onset of lupus nephritis in Chinese patients: prevalence and clinical outcomes.

Authors:  Rong Rong; Qiong Wen; Yating Wang; Qian Zhou; Yagui Qiu; Miaoqing Lu; Xiaotian Liu; Wei Chen; Xueqing Yu
Journal:  J Hum Hypertens       Date:  2021-03-08       Impact factor: 3.012

8.  Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort.

Authors:  Kunihiro Ichinose; Mineaki Kitamura; Shuntaro Sato; Keita Fujikawa; Yoshiro Horai; Naoki Matsuoka; Masahiko Tsuboi; Fumiaki Nonaka; Toshimasa Shimizu; Remi Sumiyoshi; Tomohiro Koga; Shin-Ya Kawashiri; Naoki Iwamoto; Takashi Igawa; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Tomoya Nishino; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2020-07-22       Impact factor: 5.156

Review 9.  Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.

Authors:  Myrto Kostopoulou; Antonis Fanouriakis; Kim Cheema; John Boletis; George Bertsias; David Jayne; Dimitrios T Boumpas
Journal:  RMD Open       Date:  2020-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.